Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT01792050. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the effects, good and/or bad, of standard of care therapy (docetaxel or paclitaxel) with or without the addition of 1-Methyl-D-tryptophan (referred to as indoximod) an experimental drug to find out which treatment is better.
Study identification
- NCT ID
- NCT01792050
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 169 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013
- Primary completion
- Jun 30, 2016
- Completion
- Jul 6, 2017
- Last update posted
- May 27, 2020
2013 – 2017
United States locations
- U.S. sites
- 28
- U.S. states
- 13
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Florida Health Cancer Center | Gainesville | Florida | 32610 | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| Space Coast Cancer Center | Titusville | Florida | 32796 | — |
| Cleveland Clinic - Florida | Weston | Florida | 33331 | — |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | — |
| Georgia Regents University | Augusta | Georgia | 30912 | — |
| Illinois Cancer Specialists | Arlington Heights | Illinois | 60005 | — |
| University of Illinois Cancer Center | Chicago | Illinois | 60612 | — |
| Indiana University Health Goshen Center for Cancer Care | Goshen | Indiana | 45626 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Eastchester Center for Cancer Care | The Bronx | New York | 10469 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Wake Forest Baptist Hospital | Winston-Salem | North Carolina | 27157 | — |
| Fairview Hospital | Cleveland | Ohio | 44111 | — |
| Cleveland Clinic - Taussig Cancer Center | Cleveland | Ohio | 44195 | — |
| Taussig Cancer Institute | Mayfield Heights | Ohio | 44124 | — |
| Bryn Mawr Hospital | Bryn Mawr | Pennsylvania | 19010 | — |
| Pennsylvania State University Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Paoli Hospital | Paoli | Pennsylvania | 19301 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
| University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| MD Anderson Cancer Center | Houston | Texas | 77303 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
| Lynchburg Hematology Oncology | Lynchburg | Virginia | 24501 | — |
| Peninsula Cancer Center | Newport News | Virginia | 23601 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Wheaton Franciscan Healthcare- Reiman Cancer Center | Franklin | Wisconsin | 53132 | — |
| Aurora Baycare | Green Bay | Wisconsin | 54311 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01792050, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2020 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01792050 live on ClinicalTrials.gov.